Insider Shareholders with Direct Ownership of Cardiff Oncology, Inc. (CRDF)
This section provides a comprehensive overview of the insiders with direct ownership of Cardiff Oncology, Inc. (CRDF). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Cardiff Oncology, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Gary W Pace
Director |
224,500 | 0 | 697,761 $1.54 Million | 6 |
Dec 19, 2023
Added 4.12%
|
|
James E. Levine
Chief Financial Officer |
60,000 | 0 | 60,000 $132,600 | 2 |
Sep 16, 2022
Added 33.33%
|
|
Mark Erlander
Chief Executive Officer |
11,225 | 113 | 24,481 $54,103 | 4 |
Nov 25, 2022
Added 29.0%
|
| 2,370 | 0 | 21,922 $48,447 | 1 |
Mar 23, 2021
Added 2.1%
|
|
|
James O Armitage
Director |
4,000 | 0 | 14,490 $32,022 | 1 |
Mar 19, 2021
Added 21.63%
|
| 3,000 | 0 | 12,260 $27,094 | 1 |
Mar 22, 2021
Added 19.66%
|
|
|
Renee P Tannenbaum
Director |
10,000 | 0 | 10,000 $22,100 | 1 |
Sep 15, 2022
Added 26.47%
|
|
Vicki Kelemen
Exec. VP and COO |
36,351 | 35,352 | 6,053 $13,377 | 5 |
Mar 23, 2021
Added 13.69%
|